Chiesi USA Inc - Strategic SWOT Analysis Review
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy GlobalDatas summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.
Highlights
Chiesi USA Inc (Chiesi USA) is a subsidiary of Chiesi Farmaceutici SpA, a specialty pharmaceutical company. It researches, develops, produces and commercializes therapies in cardiovascular, respiratory, neonatology, rare disease, and special care therapeutics. The companys product portfolio comprises of Cardene I.V. (nicardipine hydrochloride); Curosurf (poractant alfa); Zyflo (zileuton), Bethkis (tobramycin), Argatroban injection (Argatroban), Pertzye (pancrelipase), Kengreal (cangrelor), Cleviprex (clevidipine) and Retavase (reteplase). It offers products to retail pharmacy chains, wholesalers, group purchasing organizations, hospital systems and specialty pharmacies. Chiesi USA is headquartered in Cary, North Carolina, the US.
Chiesi USA Inc Key Recent Developments
Mar 18,2021: Chiesi Group announces performance growth in 2020
Jan 21,2021: Chiesi USA announces key promotions to business unit leads
Dec 08,2020: Chiesi USA appoints Jon Zwinski as General Manager and Chief Executive Officer
Nov 11,2020: Chiesi USA earns fourth consecutive Corporate Philanthropy Award by Triangle Business Journal
Jul 16,2020: Chiesi publishes its annual report: Group generates almost 2 billion and obtains B Corp certification in 2019
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with GlobalDatas detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
List of Tables
List of Figures
Section 1 - About the Company
Chiesi USA Inc - Key Facts
Chiesi USA Inc - Key Employees
Chiesi USA Inc - Key Employee Biographies
Chiesi USA Inc - Key Operational Employees
Chiesi USA Inc - Major Products and Services
Chiesi USA Inc - History
Chiesi USA Inc - Company Statement
Chiesi USA Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Chiesi USA Inc - Business Description
Chiesi USA Inc - SWOT Analysis
SWOT Analysis - Overview
Chiesi USA Inc - Strengths
Chiesi USA Inc - Weaknesses
Chiesi USA Inc - Opportunities
Chiesi USA Inc - Threats
Chiesi USA Inc - Key Competitors
Section 3 Companys Lifesciences Financial Deals and Alliances
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Chiesi USA Inc, Recent Deals Summary
Section 4 Companys Recent Developments
Mar 18, 2021: Chiesi Group announces performance growth in 2020
Jan 21, 2021: Chiesi USA announces key promotions to business unit leads
Dec 08, 2020: Chiesi USA appoints Jon Zwinski as General Manager and Chief Executive Officer
Nov 11, 2020: Chiesi USA earns fourth consecutive Corporate Philanthropy Award by Triangle Business Journal
Jul 16, 2020: Chiesi publishes its annual report: Group generates almost 2 billion and obtains B Corp certification in 2019
Mar 31, 2020: Chiesi USA increases support measures for employees, patients and community partners in response to COVID-19 pandemic
Feb 27, 2020: Chiesi Global Rare Diseases recognizes Rare Disease Day and highlights plans to expand focus on Patient Advocacy in 2020
Section 5 Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List Of Tables
List of TablesChiesi USA Inc, Key Facts
Chiesi USA Inc, Key Employees
Chiesi USA Inc, Key Employee Biographies
Chiesi USA Inc, Key Operational Employees
Chiesi USA Inc, Major Products and Services
Chiesi USA Inc, History
Chiesi USA Inc, Subsidiaries
Chiesi USA Inc, Key Competitors
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Chiesi USA Inc, Recent Deals Summary
List Of Figures
List of FiguresChiesi USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Chiesi USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Chiesi USA, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Chiesi USA, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportMarketlines Chiesi USA, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,
USD 350 View ReportChiesi Farmaceutici S. P. A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Chiesi Farmaceutici S. P. A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportMarketlines Chiesi Farmaceutici S. P. A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
USD 350 View ReportACUTRONIC USA Inc - Strategy, SWOT and Corporate Finance Report
ACUTRONIC USA Inc - Strategy, SWOT and Corporate Finance ReportACUTRONIC USA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report
USD 175 View ReportLOreal USA Inc - Strategic SWOT Analysis Review
LOreal USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information
USD 125 View ReportFill The Form For Sample Request